ArticleThe Lancet regional health. Europe2021
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data.
Article in The Lancet regional health. Europe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Incidence of acute pancreatitis among hospitalized patients with dengue: A systematic review and meta-analysis.PLoS neglected tropical diseases · 2026Pooled it
- Territorial inequities in access to essential medicines for neglected tropical diseases in a decentralised European health system: a nationwide assessment in Spain.Infectious diseases of poverty · 2026Article
- Building a One Health mobile laboratory workforce: strengthening public health preparedness across Europe and Africa.Human resources for health · 2026Article
- Cost effects of using point-of-care multiplex PCR for high consequence infectious diseases suspect cases.Infection · 2026Article
- Epidemiology of Imported Cutaneous Leishmaniasis: A Narrative Review.Microorganisms · 2026Review
- Safety of the Dengue Vaccine TAK-003 and Factors Associated with Adverse Events in Travellers from Non-Endemic Areas: A Real-World Prospective Multicentre Pharmacovigilance Cohort Study in Spain.The Lancet regional health. Europe · 2026Article
- Exploring the World, Minimizing Risks: Travelers' Awareness and Risk Perception of Infectious Diseases in the Post-Pandemic Era.Vaccines · 2026Article
- Traveling with HIV.Tropical diseases, travel medicine and vaccines · 2026Review
- Infections After International Travel: Relevant Diagnoses in Children and Adolescents.Deutsches Arzteblatt international · 2026Review
- Epidemiology of selected communicable diseases in Rwanda: a comprehensive analysis of the prevalence of major infectious diseases in Rwanda.International journal of emergency medicine · 2025Review
- Antibiotic therapy for severe bacterial infections.Intensive care medicine · 2025Review
- [Travel Medicine Clinic Network for the Prevention and Early Detection of Imported Infectious Diseases].Jugan geon-gang gwa jilbyeong · 2025Review
- Long-term Immunogenicity of Hepatitis A Vaccination in Adults Receiving Immunosuppressive Therapy and Adults Living With HIV: Three-year Follow-up of a Prospective Cohort Study.Open forum infectious diseases · 2025Article
- Malaria recrudescence after artemether-lumefantrine treatment in travellers- a hospital-based observational study and literature review.Tropical diseases, travel medicine and vaccines · 2025Article
- Estimating the incidence of dengue in international air travelers from non-endemic countries between 2010-2019.PLoS neglected tropical diseases · 2025Article
- Screening and Diagnosis Access for Neglected and Tropical Parasitic Diseases in Italy: A National Survey.Tropical medicine and infectious disease · 2025Article
- Risk Factors for Imported Severe Malaria Cases - China, 2019-2023.China CDC weekly · 2025Article
- Adherence to stand-by emergency treatment and mosquito protection measures in short-term travellers to moderate malaria risk areas.New microbes and new infections · 2025Article
- Use of ProMED as a Surveillance System for Emerging and Re-Emerging Infectious Diseases in Brazil from 2015 to 2020.Viruses · 2025Article
- Modelling the Lodi, 2023 and Fano 2024, Italy Dengue Outbreaks: The Effects of Control Strategies and Environmental Extremes.Transboundary and emerging diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Funding
Abstract
backgroundDisease epidemiology of (re-)emerging infectious diseases is changing rapidly, rendering surveillance of travel-associated illness important.
methodsWe evaluated travel-related illness encountered at EuroTravNet clinics, the European surveillance sub-network of GeoSentinel, between March 1, 1998 and March 31, 2018.
findings103,739 ill travellers were evaluated, including 11,239 (10.8%) migrants, 89,620 (86.4%) patients seen post-travel, and 2,880 (2.8%) during and after travel. Despite increasing numbers of patient encounters over 20 years, the regions of exposure by year of clinic visits have remained stable. In 5-year increments, greater proportions of patients were migrants or visiting friends and relatives (VFR); business travel-associated illness remained stable; tourism-related illness decreased. Falciparum malaria was amongst the most-frequently diagnosed illnesses with 5,254 cases (5.1% of all patients) and the most-frequent cause of death (risk ratio versus all other illnesses 2.5:1). Animal exposures requiring rabies post-exposure prophylaxis increased from 0.7% (1998-2002) to 3.6% (2013-2018). The proportion of patients with seasonal influenza increased from zero in 1998-2002 to 0.9% in 2013-2018. There were 44 cases of viral haemorrhagic fever, most during the past five years. Arboviral infection numbers increased significantly as did the range of presenting arboviral diseases, dengue and chikungunya diagnoses increased by 2.6% and 1%, respectively.
interpretationTravel medicine must adapt to serve the changing profile of travellers, with an increase in migrants and persons visiting relatives and friends and the strong emergence of vector-borne diseases, with potential for further local transmission in Europe.
fundingThis project was supported by a cooperative agreement (U50CK00189) between the Centers for Disease Control and Prevention to the International Society of Travel Medicine (ISTM) and funding from the ISTM and the Public Health Agency of Canada.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.